BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
ARROWHEAD RESEARCH (NQ: ARWR)
12.97 USD  -0.55 (-4.07%)
Streaming Delayed Price  /  Updated: 1:11 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(ARWR) Community Analysis from
Bears REASONS TO SELL
April 23, 2014
(, 12/15/11)
I don't have the time to write a post about this transaction at the moment, but here is a collection of links related to this deal in the RNAi space (relevant to Alnylam...(read more)
(Benzinga, 9/29/10)
Arrowhead Research Corporation's (NASDAQ: ARWR) President and Chief Executive Officer today issued the following open letter to the Company's shareholders: Highlights: Let us start with an overview of some of Arrowhead's...(read more)
Arrowhead Research (ARWR) Company Overview

There is no analysis for ARWR yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here